Millennium Pharmaceuticals, Inc. (MLNM)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
3044	135	0	MLNM

Emcee: icanpickem	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1969	1: Blood. 2003 Dec 11 [Epub ahead of print]. Related Articles, Links Borte	Icebrg	-	12/16/2003
1968	<i>There is, undoubtedly, enormous focus at Bayer to weed through the pros	nigel bates	-	12/16/2003
1967	Survey of Oncologists Reveals Significant Opportunity to Get More Multiple Myelo	nigel bates	-	12/15/2003
1966	Independent Committee Recommends Early End to Confirmatory Phase III VELCADE Tri	nigel bates	-	12/15/2003
1965	GS report: 12/9 At a cancer meeting, MLNM presented encouraging preliminary da	mopgcw	-	12/14/2003
1964	MLNM was up 4.59% for the week although biotech stocks in general changed little	blackmerlin	-	12/12/2003
1963	Early Research Advances Field of Proteasome Biology Thursday December 11, 2:00 p	IRWIN JAMES FRANKEL	-	12/11/2003
1962	OT <<Typical Genta release.... how many of the 12 were T naive?>>	Miljenko Zuanic	-	12/9/2003
1961	well i agree that there's a little smoke with genta but they also completed	bob zagorin	-	12/9/2003
1960	<i>In a Phase 1-2 clinical study from the University of Maryland, 25 patie	scaram(o)uche	-	12/9/2003
1959	see below - a GNTA study which includes results on combo with Velcade.... Genase	bob zagorin	-	12/9/2003
1958	Preliminary Study Results of VELCADE(TM) (bortezomib) for Injection Combined Wit	scaram(o)uche	-	12/9/2003
1957	Thanks Richard, At least if I am being deceived we are learning it from the sam	IRWIN JAMES FRANKEL	-	12/9/2003
1956	I.J.: You want to know if the rug is suddenly going to be pulled out from under	scaram(o)uche	-	12/9/2003
1955	Morning Richard, I'm always interested in what the science types think abou	IRWIN JAMES FRANKEL	-	12/9/2003
1954	<b>G-S Research Release THIS morning:</b> At a cancer meeting, MLNM	PCSS	-	12/9/2003
1953	This isn't Millennium reporting. These are presentations by clinical invest	scaram(o)uche	-	12/9/2003
1952	IJ, Thanks for your efforts. I guess I find the snail's pace somewhat frus	Ian@SI	-	12/8/2003
1951	Ian, I have compared the slides to the PR's today. The PR does include mor	IRWIN JAMES FRANKEL	-	12/8/2003
1950	IJ, Presentation is being emailed to you as I type this. The PR that you poste	Ian@SI	-	12/8/2003
1949	Hi IAN, Reporting a study with a different investigator that was the same study	IRWIN JAMES FRANKEL	-	12/8/2003
1948	IJ, I looked at the presentation given to ASCO this year. While Goy's resu	Ian@SI	-	12/8/2003
1947	New Phase II Findings Support Potential Role of VELCADE(TM) (bortezomib) for Inj	IRWIN JAMES FRANKEL	-	12/8/2003
1946	Preliminary Phase II Results With VELCADE(TM) (Bortezomib) For Injection Demonst	Ian@SI	-	12/8/2003
1945	Millennium gets fast track for prostate cancer drug Thursday December 4, 8:16 am	manny t	-	12/4/2003

Go to reply# or date (mm/dd/yy):